Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12–49 (2024).

Article  PubMed  Google Scholar 

Thompson, I. et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J. Urol. 177, 2106–2131 (2007).

Article  PubMed  Google Scholar 

Abdollah, F. et al. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Eur. Urol. 67, 212–219 (2015).

Article  PubMed  Google Scholar 

Deng, J. Y. & Liang, H. Clinical significance of lymph node metastasis in gastric cancer. World J. Gastroenterol. 20, 3967–3975 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Song, Y. J. et al. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer. J. Breast Cancer 14, 198–203 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Murakami, Y. et al. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J. Am. Coll. Surg. 211, 196–204 (2010).

Article  PubMed  Google Scholar 

Pereira, E. R., Jones, D., Jung, K. & Padera, T. P. The lymph node microenvironment and its role in the progression of metastatic cancer. Semin. Cell Dev. Biol. 38, 98–105 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

du Bois, H., Heim, T. A. & Lund, A. W. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci. Immunol. 6, eabg3551 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Gervasoni, J. E. Jr., Sbayi, S. & Cady, B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann. Surg. Oncol. 14, 2443–2462 (2007).

Article  PubMed  Google Scholar 

Moschini, M. et al. Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection. Prostate Cancer Prostatic Dis. 19, 63–67 (2016).

Article  CAS  PubMed  Google Scholar 

Bivalacqua, T. J. et al. Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology 82, 653–658 (2013).

Article  PubMed  Google Scholar 

Joslyn, S. A. & Konety, B. R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68, 121–125 (2006).

Article  PubMed  Google Scholar 

Engel, J. et al. Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur. Urol. 57, 754–761 (2010).

Article  PubMed  Google Scholar 

Chen, J. et al. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database. Sci. Rep. 9, 17985 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Fossati, N. et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur. Urol. 72, 84–109 (2017).

Article  PubMed  Google Scholar 

Nocera, L. et al. Rate and extent of pelvic lymph node dissection in the US prostate cancer patients treated with radical prostatectomy. Clin. Genitourin. Cancer 16, e451–e467 (2018).

Article  PubMed  Google Scholar 

Lowrance, W. T. et al. Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J. Urol. 187, 2087–2092, (2012).

Article  PubMed  PubMed Central  Google Scholar 

Fransen, M. F., van Hall, T. & Ossendorp, F. Immune checkpoint therapy: tumor draining lymph nodes in the spotlights. Int. J. Mol. Sci. 22, 9401 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. JCI Insight 3, e124507 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Fransen, M. F., Arens, R. & Melief, C. J. Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment. Int. J. Cancer 132, 1971–1976 (2013).

Article  CAS  PubMed  Google Scholar 

Fletcher, A. L. & Heng, T. S. Lymph node stroma join the cancer support network. Cell Death Differ. 23, 1899–1901 (2016).

Article  PubMed  PubMed Central  Google Scholar 

van Pul, K. M., Fransen, M. F., van de Ven, R. & de Gruijl, T. D. Immunotherapy goes local: the central role of lymph nodes in driving tumor infiltration and efficacy. Front. Immunol. 12, 643291 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1–10 (2013).

Article  PubMed  Google Scholar 

Cochran, A. J. et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat. Rev. Immunol. 6, 659–670 (2006).

Article  CAS  PubMed  Google Scholar 

Loeb, S., Partin, A. W. & Schaeffer, E. M. Complications of pelvic lymphadenectomy: do the risks outweigh the benefits? Rev. Urol. 12, 20–24 (2010).

PubMed  PubMed Central  Google Scholar 

Briganti, A. et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur. Urol. 50, 1006–1013 (2006).

Article  PubMed  Google Scholar 

Epstein, J. I. et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand. J. Urol. Nephrol. Suppl. 34–63 (2005).

D’Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969–974, (1998).

Article  PubMed  Google Scholar 

Cagiannos, I. et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J. Urol. 170, 1798–1803 (2003).

Article  PubMed  Google Scholar 

Partin, A. W. et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. 150, 110–114 (1993).

Article  CAS  PubMed  Google Scholar 

Briganti, A. et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur. Urol. 61, 480–487 (2012).

Article  PubMed  Google Scholar 

Martini, A. et al. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of magnetic resonance imaging-targeted biopsy: a study that challenges the dogma. J. Urol. 210, 117–127 (2023).

Article  PubMed  Google Scholar 

Cheng, L. et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91, 66–73 (2001).

Article  CAS  PubMed  Google Scholar 

Gervasi, L. A. et al. Prognostic significance of lymph nodal metastases in prostate cancer. J. Urol. 142, 332–336 (1989).

Article  CAS  PubMed